BUVIDAL Trademark

Trademark Overview


On Monday, May 28, 2018, a trademark application was filed for BUVIDAL with the United States Patent and Trademark Office. The USPTO has given the BUVIDAL trademark a serial number of 79236518. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2019. This trademark is owned by Camurus AB. The BUVIDAL trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; veterinary pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; sanitary preparations for medical purposes; d...

Medical services; veterinary services; consultancy relating to medicines in the nature of providing medical consultancy services

Scientific and technological services and research, development and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicines, all for use in the fields of treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, treatment of opiate and chemical addictions, treatment of co-morbidities associated with substance use disorders, treatment of mental health diseases and disorders, treatment of central nervous system diseases and disorders, and management and relief of pain; chemical laboratories; chemical research, chemical analysis; research in the fields of medicines, foods, cosmetics and biotechnology; development of technical know-how, namely, technical advice, information, support and consultancy namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicine, all in the fields of the treatment of subs...
buvidal

General Information


Serial Number79236518
Word MarkBUVIDAL
Filing DateMonday, May 28, 2018
Status700 - REGISTERED
Status DateTuesday, December 24, 2019
Registration Number5940519
Registration DateTuesday, December 24, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; veterinary pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; sanitary preparations for medical purposes; dietetic substances, namely dietetic beverages and dietetic sugar adapted for medical use, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; plasters for medical purposes, materials for dressings, namely, medical dressings, all for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; disinfectants; preparations for destroying vermin; fungicides, herbicides
Goods and ServicesMedical services; veterinary services; consultancy relating to medicines in the nature of providing medical consultancy services
Goods and ServicesScientific and technological services and research, development and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicines, all for use in the fields of treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, treatment of opiate and chemical addictions, treatment of co-morbidities associated with substance use disorders, treatment of mental health diseases and disorders, treatment of central nervous system diseases and disorders, and management and relief of pain; chemical laboratories; chemical research, chemical analysis; research in the fields of medicines, foods, cosmetics and biotechnology; development of technical know-how, namely, technical advice, information, support and consultancy namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicine, all in the fields of the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, the treatment of opiate and chemical addictions, the treatment of co-morbidities associated with substance use disorders, the treatment of mental health diseases and disorders, the treatment of central nervous system diseases and disorders, and management and relief of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 14, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 14, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCamurus AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE

Party NameCamurus AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE

Party NameCamurus AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events


Event DateEvent Description
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 6, 2020FINAL DISPOSITION PROCESSED
Tuesday, March 24, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, January 3, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, December 24, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Friday, October 4, 2019NOTIFICATION PROCESSED BY IB
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Thursday, August 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 27, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 22, 2019FINAL REFUSAL MAILED
Sunday, April 21, 2019FINAL REFUSAL WRITTEN
Saturday, March 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 12, 2018REFUSAL PROCESSED BY IB
Tuesday, September 25, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 25, 2018REFUSAL PROCESSED BY MPU
Tuesday, September 18, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 17, 2018NON-FINAL ACTION WRITTEN
Monday, September 17, 2018ASSIGNED TO EXAMINER
Wednesday, July 18, 2018APPLICATION FILING RECEIPT MAILED
Saturday, July 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 12, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB